MolNFT v1 · #31918 · protein
P38ALPHA bound to RO3201195
2BAQ · Mitogen-activated protein kinase 14: “P38ALPHA bound to RO3201195”. X-ray diffraction, 1 ligand (PQB), 6 pockets (best druggability 0.69). MolNFT v1 #31918 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2BAQ
- Type
- protein
- Length
- 330 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Mitogen-activated protein kinase 14
- EC
- 2.7.1.37
- UniProt
- Q16539
- Ligands
- PQB
- Pockets
- 6 · best druggability 0.69
Structure
x-ray diffraction · 1 distinct chain · 38% helix, 15% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Mitogen-activated protein kinase 14 (EC 2.7.1.37) | protein | 330 | 38% helix, 15% strand | Q16539 |
Ligands and binding sites
- PQB · [5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl](3-{[(2R)-2,3-dihydroxypropyl]oxy}phenyl)methanone · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 197 | 0.69 | 0.86 | 36 | PQB |
| 2 | 215 | 0.60 | 0.81 | 26 | empty |
| 3 | 122 | 0.41 | 0.75 | 19 | empty |
| 4 | 65 | 0.32 | 0.75 | 18 | empty |
| 5 | 58 | 0.29 | 0.74 | 14 | empty |
Modifications
Observed in the structure: 1 modified (oxidation).
Compared structures
- 2BAQ · p38alpha bound to Ro3201195 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q16539
- Elsewhere: RCSB PDB 2BAQ · PDBe 2BAQ · UniProt Q16539
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.